First patients to test experimental cancer pill in groundbreaking trial
NCT ID NCT06801002
Summary
This is the first human study of an experimental cancer drug called JBZ-001. Researchers are testing it in 25 adults with advanced solid tumors or blood cancers that haven't responded to standard treatments. The main goals are to find a safe dose and see how the body processes the drug, while also looking for early signs that it might help control cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
START Mountain Region
RECRUITINGWest Valley City, Utah, 84119, United States
Contact
Contact Email: •••••@•••••
-
The Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
Contact
Conditions
Explore the condition pages connected to this study.